In addition, although SAMM50 did not show significant RFS or OS in survival analysis, other studies have shown that SAMM50 is associated with nonalcoholic fatty liver disease and affects drP1-dependent mitochondrial morphology [23, 24]. The gene discussed is SAMM50; the disease is metabolic dysfunction-associated steatotic liver disease.